论文信息 - Drug discovery: A question of library design - 字舞流文

Drug discovery: A question of library design

Two approaches have emerged for creating libraries of compounds for use in biological screening assays for drug discovery — fragment-based ligand design and diversity-oriented synthesis. Advocates of each approach discuss their favoured strategy.

Warren R. J. D. Galloway | David R. Spring | Philip J. Hajduk | P. Hajduk | D. Spring | W. R. Galloway | D. R. Spring | W. Galloway

[1] P. Hajduk,et al. Discovering High-Affinity Ligands for Proteins , 1997, Science.

[2] D. Erlanson. Fragment-based lead discovery: a chemical update. , 2006, Current opinion in biotechnology.

[3] David R Spring,et al. Diversity-oriented synthesis as a tool for the discovery of novel biologically active small molecules. , 2010, Nature communications.

[4] Maurizio Pellecchia,et al. Identification of lead compounds as antagonists of protein Bcl-xL with a diversity-oriented multidisciplinary approach. , 2009, Journal of medicinal chemistry.

[5] P. Hajduk,et al. Puzzling through fragment-based drug design , 2006, Nature chemical biology.

[6] P. Hajduk,et al. A decade of fragment-based drug design: strategic advances and lessons learned , 2007, Nature Reviews Drug Discovery.

[7] Stuart L. Schreiber,et al. Organic chemistry: Molecular diversity by design , 2009, Nature.

[8] P. Leeson,et al. The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[9] Peter Meier,et al. Key aspects of the Novartis compound collection enhancement project for the compilation of a comprehensive chemogenomics drug discovery screening collection. , 2005, Current topics in medicinal chemistry.